Next generation, 'Standards-Free' Metabolite Identification Pipeline
Next generation, 'Standards-Free' Metabolite Identification Pipeline
批准号:
9433322
负责人:
Thomas O Metz
金额:
$19.01万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-21 至 2019-08-31
关键词:
AlcoholsAlkaloidsAmino AcidsAntioxidantsAttributes of ChemicalsBiologicalBiological MarkersBiomedical ResearchCarbohydratesChemicalsClinicalCollaborationsCommunitiesComplexComputer SimulationComputing MethodologiesConstitutionalCoupledDataData AnalysesDatabasesDependencyDevice or Instrument DevelopmentDietDiseaseEnvironmentEnvironmental ExposureFlavonoidsFundingGasesGenomeGeometryGlycosidesGoalsHealthHumanIndividualInsulin-Dependent Diabetes MellitusIsomerismIsotopesKnowledgeLaboratoriesLibrariesLipidsMass Spectrum AnalysisMeasurementMeasuresMetabolicMethodsMissionMolecularNucleotidesOutcomePacific NorthwestPeptidesPhasePropertyResearchResearch PersonnelResearch Project GrantsResolutionResourcesRoleSamplingScienceSiblingsSpectrometrySpeedStandardizationSteroidsStructureSupercomputingUnited States National Institutes of HealthUrineValidationVitaminsWorkbasebiomarker discoverychemical propertychemical standardcheminformaticscombinatorialcomparativecomputational chemistrycomputerized toolsdiagnosis evaluationdisease diagnosisgenetic informationgenome sequencinginnovationinstrumentationion mobilitymetabolomemetabolomicsmolecular dynamicsnext generationnon-diabeticnon-geneticopen sourceorganic acidquantumquantum chemistrysimulationsmall moleculesmall molecule librariestooltype I diabetic
中文摘要
研究计划摘要
对临床样本中数以千计的代谢物和其他化学物质进行化学鉴定的能力将带来革命性的变化
寻找疾病的环境、饮食和代谢决定因素。与近乎全面的
遗传信息,对人类代谢组的整体了解相对较少,主要是由于
分子鉴定方法的不足。通过计算化学的创新,我们建议
克服代谢组学领域长期存在的一个重大障碍:缺乏准确和
全面识别小分子,而不依赖于分析可信的化学标准的数据。一个
在代谢组学的范式转换中,我们将利用气相分子的性质,碰撞截面,即可以
通过计算准确预测,并通过实验进行一致测量,因此可以用于
代谢物的全面鉴定,不需要真实的化学标准。这样做的结果是
该提案直接推动了NIH共同基金的使命和目标:(I)通过以下方式转变代谢组学
通过对当前代谢组的优化识别,能够考虑人类代谢组的整体
无法识别的分子,最终达到数十万个分子,以及(Ii)开发标准化
提高生物医学研究人员快速识别代谢物的国家能力的计算工具
准确地说。这项工作意义重大,因为它使全面和可信的化学测量成为可能
代谢体。这项工作具有创新性,因为它利用了高通量、高精度、基于量子化学的
计算和化学信息学平台从一开始预测代谢物的物理化学性质
原则。
英文摘要
Research Plan Abstract
The capability to chemically identify thousands of metabolites and other chemicals in clinical samples will revolutionize
the search for environmental, dietary, and metabolic determinants of disease. By comparison to near-comprehensive
genetic information, comparatively little is understood of the totality of the human metabolome, largely due to
insufficiencies in molecular identification methods. Through innovations in computational chemistry, we propose to
overcome a significant, long standing obstacle in the field of metabolomics: the absence of methods for accurate and
comprehensive identification of small molecules without relying on data from analysis of authentic chemical standards. A
paradigm shift in metabolomics, we will use a gas-phase molecular property, collision cross section, that can be both
accurately predicted computationally and consistently measured experimentally, and which can thus be used for
comprehensive identification of the metabolome without the need for authentic chemical standards. The outcomes of this
proposal directly advance the mission and goals of the NIH Common Fund by: (i) transforming metabolomics science by
enabling consideration of the totality of the human metabolome through optimized identification of currently
unidentifiable molecules, eventually reaching hundreds of thousands of molecules, and (ii) developing standardized
computational tools to increase the national capacity for biomedical researchers to identify metabolites quickly and
accurately. This work is significant because it enables comprehensive and confident chemical measurement of the
metabolome. This work is innovative because it utilizes a high throughput, high accuracy, quantum-chemistry-based
computational and chemical informatics platform to predict physical-chemical properties of metabolites from first
principles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Integrated Stress Response in Human Islets During Early T1D
-
批准号:10592566
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2020
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:9769745
-
项目类别:
-
资助金额:$99.86万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Administrative Core
-
批准号:10213203
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10260964
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10213202
-
项目类别:
-
资助金额:$98.16万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Pacific Northwest Advanced Compound Identification Core
-
批准号:10012251
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Label-free polar metabolite quantification for untargeted metabolomics
-
批准号:10396924
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2018
-
负责人:Thomas O Metz
-
依托单位:
Validation of Novel Peptide/Protein Markers for Diagnosis of Type 1 Diabetes
-
批准号:8495451
-
项目类别:
-
资助金额:$92.38万
-
财政年份:2012
-
负责人:Thomas O Metz
-
依托单位:
Administrative Core
-
批准号:9769747
-
项目类别:
-
资助金额:$17.78万
-
财政年份:--
-
负责人:Thomas O Metz
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: